Key result
Endovascular correction in neonatal CHD shows acceptable stability despite a ~46% reintervention rate for recoarctation.
Why the study?
Does individualized anesthetic management provide safe perioperative conditions for endovascular correction of critical congenital heart disease in neonates and infants?
Observational (n=139)
No
Does individualized anesthetic management provide safe perioperative conditions for endovascular correction of critical congenital heart disease in neonates and infants?
Individualized anesthetic strategies, including ketamine-based sedation, enable safe and hemodynamically stable transcatheter interventions in neonates and infants with critical congenital heart disease.
No takes yet. Share an insight, caveat, or question.
Supports individualized ketamine-based anesthesia for stable endovascular correction in neonates; leaves open durability and selection questions for prospective trials.
Imanov et al. (2026) conducted an observational in Neonates and infants under one year of age with critical congenital heart disease undergoing endovascular correction (n=139). Endovascular correction of critical congenital heart defects was evaluated on Early perioperative outcomes including hemodynamic stability, complications, ventilatory support requirements, and mortality. Endovascular correction in neonates and infants with critical congenital heart disease showed acceptable perioperative stability with 8.5% mortality after balloon aortic valvuloplasty and 0% mortality after balloon angioplasty for coarctation but 46.4% reintervention rate for recoarctation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: